Patent Board Grants Review Of Oral Pulsed Dosed Drug Delivery System Patent
ALEXANDRIA, Va. — Arguments by Mylan Pharmaceuticals Inc. that a patented drug delivery system associated with the attention deficit hyperactivity disorder (ADHD) drug Adderall XR is invalid were well received Nov....To view the full article, register now.
Already a subscriber? Click here to view full article